Drug interactions between Bexxar and Iodotope
|Bexxar (iodine i 131 tositumomab)|
|Iodotope (sodium iodide-i-131)|
Interactions between your drugs
There were no interactions found in our database between Bexxar and Iodotope - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Bexxar is in the following drug classes: CD20 monoclonal antibodies, therapeutic radiopharmaceuticals.
- Bexxar is used to treat Non-Hodgkin's Lymphoma.
- Iodotope is a member of the following drug classes: antithyroid agents, therapeutic radiopharmaceuticals.
- Iodotope is used to treat the following conditions:
Drug and food interactions
sodium iodide I-131 food
Applies to: Iodotope (sodium iodide-i-131)
Iodine may interfere with the uptake of sodium iodide I-131 by the thyroid . A diet low in iodine and iodinated salt is recommended before starting therapy with sodium iodide I-131.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'radiopharmaceutical agents' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'radiopharmaceutical agents' category:
- Bexxar (iodine i 131 tositumomab)
- Iodotope (sodium iodide-i-131)
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.